Cara Therapeutics | CARA - Market Capitalization

Stock Price
4.02
Daily Change
0 0%
Monthly
13.24%
Yearly
-70.22%
Q1 Forecast
3.87

Cara Therapeutics reported $219.7M in Market Capitalization this March of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Acadia Pharmaceuticals USD 4.52B 919M Dec/2025
Alterity Therapeutics Limited AUD 11M 5M Jun/2023
Cara Therapeutics USD 28M 11M Dec/2024
Cassava Sciences USD 141M 54M Sep/2025
Chugai Pharma JPY 13.84T 3.01T Dec/2025
Cipla INR 1.22T 6.47B Dec/2025
Clal Biotechnology ILS 47.99M 4.37M Jan/2026
Compugen USD 137.5M 21.89M Sep/2025
CSL USD 71.32B 15.44B Mar/2026
Grifols EUR 6.77B 773M Sep/2025
Halozyme Therapeutics USD 7.91B 664M Dec/2025
J&J USD 500.24B 67.44B Dec/2025
Neurocrine Biosciences USD 14.14B 218M Dec/2025
Pacira USD 1.06B 94M Dec/2025
Pfizer USD 141.57B 6.48B Dec/2025
RedHill Biopharma USD 12M 17M Jun/2024
Supernus Pharmaceuticals USD 2.85B 151M Dec/2025
Vanda Pharmaceuticals USD 279M 6M Dec/2024